Cargando…
RANK-RANKL Signaling in Cancer of the Uterine Cervix: A Review
RANK ligand (RANKL) is a member of the tumor necrosis factor alpha superfamily of cytokines. It is the only known ligand binding to a membrane receptor named receptor activator of nuclear factor-kappa B (RANK), thereby triggering recruitment of tumor necrosis factor (TNF) receptor associated factor...
Autores principales: | van Dam, Peter A., Verhoeven, Yannick, Jacobs, Julie, Wouters, An, Tjalma, Wiebren, Lardon, Filip, Van den Wyngaert, Tim, Dewulf, Jonatan, Smits, Evelien, Colpaert, Cécile, Prenen, Hans, Peeters, Marc, Lammens, Martin, Trinh, Xuan Bich |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6540175/ https://www.ncbi.nlm.nih.gov/pubmed/31052546 http://dx.doi.org/10.3390/ijms20092183 |
Ejemplares similares
-
Targeting the PD-1 Axis with Pembrolizumab for Recurrent or Metastatic Cancer of the Uterine Cervix: A Brief Update
por: Verhoeven, Yannick, et al.
Publicado: (2021) -
Immuno-PET Molecular Imaging of RANKL in Cancer
por: Dewulf, Jonatan, et al.
Publicado: (2021) -
Cancer-Associated Fibroblasts as a Common Orchestrator of Therapy Resistance in Lung and Pancreatic Cancer
por: Domen, Andreas, et al.
Publicado: (2021) -
SARS-CoV-2 and cancer: Are they really partners in crime?
por: van Dam, Peter A., et al.
Publicado: (2020) -
Improved Characteristics of RANKL Immuno-PET Imaging Using Radiolabeled Antibody Fab Fragments
por: Dewulf, Jonatan, et al.
Publicado: (2022)